Literature DB >> 26968988

The roles of HOXB7 in promoting migration, invasion, and anti-apoptosis in gastric cancer.

Moon Kyung Joo1, Jong-Jae Park2, Hyo Soon Yoo1, Beom Jae Lee1, Hoon Jai Chun3, Sang Woo Lee4, Young-Tae Bak1.   

Abstract

BACKGROUND AND AIM: The aim of this study was to compare HOXB7 expression level between gastric cancer and non-cancerous gastric tissues. Additionally, the functional effects of HOXB7, including its pro-migration or invasion and anti-apoptosis roles, were evaluated in gastric cancer cells.
METHODS: Both gene and protein expression levels of HOXB7 were examined in gastric cancer cell lines, and HOXB7 expression was compared between primary or metastatic gastric cancer tissues and chronic gastritis or intestinal metaplasia tissues. Functional studies included a wound healing assay, a Matrigel invasion assay, and an Annexin-V assay were performed, and Akt/PTEN activity was measured by western blotting.
RESULTS: Both gene and protein expression levels of HOXB7 could be clearly detected in various gastric cancer cell lines except MKN-28 cell. HOXB7 expression was significantly higher in primary or metastatic gastric cancer tissues than in chronic gastritis or intestinal metaplasia tissues. HOXB7 knockdown led to inhibition of cell invasion and migration, had an apoptotic effect, downregulated phosphor-Akt, and upregulated PTEN in AGS and SNU-638 cells. Reinforced expression of HOXB7 caused the opposite effects in MKN-28 and MKN-45 cells.
CONCLUSION: Our study suggests that HOXB7 has an oncogenic role in gastric cancer, which might be related to the modulation of Akt/PTEN activity to induce cell migration/invasion and anti-apoptotic effects.
© 2016 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  Akt; HOXB7; PTEN; stomach cancer

Mesh:

Substances:

Year:  2016        PMID: 26968988     DOI: 10.1111/jgh.13330

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  8 in total

1.  The prognostic value of homeobox B7 expression in patients with hepatocellular carcinoma.

Authors:  Yarong Guo; Xiaojiang Qin; Bao Chai; Junmei Jia; Jiahong Yi; Kang Wang; Xiaomin Hou
Journal:  Int J Clin Exp Pathol       Date:  2019-07-01

Review 2.  Impact of homeobox genes in gastrointestinal cancer.

Authors:  Moon Kyung Joo; Jong-Jae Park; Hoon Jai Chun
Journal:  World J Gastroenterol       Date:  2016-10-07       Impact factor: 5.742

3.  HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition.

Authors:  Hong-Bo Huan; Da-Peng Yang; Xu-Dong Wen; Xue-Jiao Chen; Liang Zhang; Li-Li Wu; Ping Bie; Feng Xia
Journal:  J Exp Clin Cancer Res       Date:  2017-06-24

4.  CircRNA hsa_circ_0070934 functions as a competitive endogenous RNA to regulate HOXB7 expression by sponging miR‑1236‑3p in cutaneous squamous cell carcinoma.

Authors:  Da-Wei Zhang; Hai-Yan Wu; Chuan-Rong Zhu; Dong-Dong Wu
Journal:  Int J Oncol       Date:  2020-05-14       Impact factor: 5.650

5.  Downregulation of Homeobox B7 Inhibits the Tumorigenesis and Progression of Osteosarcoma.

Authors:  Lei Yang; Fei Xie; Shuangqing Li
Journal:  Oncol Res       Date:  2016-11-08       Impact factor: 5.574

6.  LncRNA MAGI2-AS3 Overexpression Sensitizes Esophageal Cancer Cells to Irradiation Through Down-Regulation of HOXB7 via EZH2.

Authors:  Wenfang Cheng; Xiuling Shi; Mingqiang Lin; Qiwei Yao; Jiayu Ma; Jiancheng Li
Journal:  Front Cell Dev Biol       Date:  2020-11-24

Review 7.  Downstream of the HOX genes: Explaining conflicting tumour suppressor and oncogenic functions in cancer.

Authors:  Richard Morgan; Keith Hunter; Hardev S Pandha
Journal:  Int J Cancer       Date:  2022-02-15       Impact factor: 7.316

8.  Upregulated expression of HOXB7 in intrahepatic cholangiocarcinoma is associated with tumor cell metastasis and poor prognosis.

Authors:  Longfei Dai; Wendi Hu; Zhenjie Yang; Diyu Chen; Bin He; Yunhao Chen; Lin Zhou; Haiyang Xie; Jian Wu; Shusen Zheng
Journal:  Lab Invest       Date:  2019-01-21       Impact factor: 5.662

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.